IL‐27 stimulates human NK‐cell effector functions and primes NK cells for IL‐18 responsiveness

IL‐27, a member of the IL‐12 family of cytokines, is produced by APCs, and displays pro‐ and anti‐inflammatory effects. How IL‐27 affects human NK cells still remains unknown. In this study, we observed that mature DCs secreted IL‐27 and that blockade of IL‐27R (CD130) reduced the amount of IFN‐γ pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of immunology 2015-01, Vol.45 (1), p.192-202
Hauptverfasser: Ziblat, Andrea, Domaica, Carolina I., Spallanzani, Raúl G., Iraolagoitia, Ximena L. Raffo, Rossi, Lucas E., Avila, Damián E., Torres, Nicolás I., Fuertes, Mercedes B., Zwirner, Norberto W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 202
container_issue 1
container_start_page 192
container_title European journal of immunology
container_volume 45
creator Ziblat, Andrea
Domaica, Carolina I.
Spallanzani, Raúl G.
Iraolagoitia, Ximena L. Raffo
Rossi, Lucas E.
Avila, Damián E.
Torres, Nicolás I.
Fuertes, Mercedes B.
Zwirner, Norberto W.
description IL‐27, a member of the IL‐12 family of cytokines, is produced by APCs, and displays pro‐ and anti‐inflammatory effects. How IL‐27 affects human NK cells still remains unknown. In this study, we observed that mature DCs secreted IL‐27 and that blockade of IL‐27R (CD130) reduced the amount of IFN‐γ produced by NK cells during their coculture, showing the importance of IL‐27 during DC–NK‐cell crosstalk. Accordingly, human rIL‐27 stimulated IFN‐γ secretion by NK cells in a STAT1‐dependent manner, induced upregulation of CD25 and CD69 on NK cells, and displayed a synergistic effect with IL‐18. Preincubation experiments demonstrated that IL‐27 primed NK cells for IL‐18‐induced IFN‐γ secretion, which was associated with an IL‐27‐driven upregulation of T‐bet expression. Also, IL‐27 triggered NKp46‐dependent NK‐cell‐mediated cytotoxicity against Raji, T‐47D, and HCT116 cells, and IL‐18 enhanced this cytotoxic response. Such NK‐cell‐mediated cytotoxicity involved upregulation of perforin, granule exocytosis, and TRAIL‐mediated cytotoxicity but not Fas‐FasL interaction. Moreover, IL‐27 also potentiated Ab‐dependent cell‐mediated cytotoxicity against mAb‐coated target cells. Taken together, IL‐27 stimulates NK‐cell effector functions, which might be relevant in different physiological and pathological situations.
doi_str_mv 10.1002/eji.201444699
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1654669039</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1654669039</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5067-b16338bb7bca7f9676a93f874190d3b6b809eaab2b7f0800c6751cfc61a3c6733</originalsourceid><addsrcrecordid>eNqN0btOIzEUBmAL7YpkgZIWWdqGZsLxfVwiBGwgggbqke3YYqK5hPEMKB2PsM-4T4KHsCm2QFvZsj_98vGP0DGBGQGgZ35VzigQzrnUeg9NiaAk44STb2gK6TyjOocJ-hHjCgC0FHofTahgkAsqp2g5X_x5-00Vjn1ZD5XpfcRPQ20afHebLpyvKuxD8K5vOxyGxvVl20RsmiVed2Wd9N0tHlXEIYmPNJLjzsd1cuWLb3yMh-h7MFX0R5_rAXq8uny4-JUt7q_nF-eLzAmQKrNEMpZbq6wzKmippNEs5IoTDUtmpc1Be2MstSpADuCkEsQFJ4lhac_YATrd5q679nnwsS_qMo6PM41vh1gQKbiUGpj-H0qZUpCPqT__oat26Jo0SFKcC6W1lEllW-W6NsbOh2L8H9NtCgLF2FSRmip2TSV_8pk62Novd_pvNQnQLXgtK7_5Oq24vJkzIhR7B8mZnnU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1644579966</pqid></control><display><type>article</type><title>IL‐27 stimulates human NK‐cell effector functions and primes NK cells for IL‐18 responsiveness</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via Wiley Online Library</source><source>Wiley Online Library (Open Access Collection)</source><creator>Ziblat, Andrea ; Domaica, Carolina I. ; Spallanzani, Raúl G. ; Iraolagoitia, Ximena L. Raffo ; Rossi, Lucas E. ; Avila, Damián E. ; Torres, Nicolás I. ; Fuertes, Mercedes B. ; Zwirner, Norberto W.</creator><creatorcontrib>Ziblat, Andrea ; Domaica, Carolina I. ; Spallanzani, Raúl G. ; Iraolagoitia, Ximena L. Raffo ; Rossi, Lucas E. ; Avila, Damián E. ; Torres, Nicolás I. ; Fuertes, Mercedes B. ; Zwirner, Norberto W.</creatorcontrib><description>IL‐27, a member of the IL‐12 family of cytokines, is produced by APCs, and displays pro‐ and anti‐inflammatory effects. How IL‐27 affects human NK cells still remains unknown. In this study, we observed that mature DCs secreted IL‐27 and that blockade of IL‐27R (CD130) reduced the amount of IFN‐γ produced by NK cells during their coculture, showing the importance of IL‐27 during DC–NK‐cell crosstalk. Accordingly, human rIL‐27 stimulated IFN‐γ secretion by NK cells in a STAT1‐dependent manner, induced upregulation of CD25 and CD69 on NK cells, and displayed a synergistic effect with IL‐18. Preincubation experiments demonstrated that IL‐27 primed NK cells for IL‐18‐induced IFN‐γ secretion, which was associated with an IL‐27‐driven upregulation of T‐bet expression. Also, IL‐27 triggered NKp46‐dependent NK‐cell‐mediated cytotoxicity against Raji, T‐47D, and HCT116 cells, and IL‐18 enhanced this cytotoxic response. Such NK‐cell‐mediated cytotoxicity involved upregulation of perforin, granule exocytosis, and TRAIL‐mediated cytotoxicity but not Fas‐FasL interaction. Moreover, IL‐27 also potentiated Ab‐dependent cell‐mediated cytotoxicity against mAb‐coated target cells. Taken together, IL‐27 stimulates NK‐cell effector functions, which might be relevant in different physiological and pathological situations.</description><identifier>ISSN: 0014-2980</identifier><identifier>EISSN: 1521-4141</identifier><identifier>DOI: 10.1002/eji.201444699</identifier><identifier>PMID: 25308526</identifier><identifier>CODEN: EJIMAF</identifier><language>eng</language><publisher>Germany: Wiley Subscription Services, Inc</publisher><subject>Antibodies, Monoclonal - pharmacology ; Antigens ; Antigens, CD - genetics ; Antigens, CD - immunology ; Antigens, Differentiation, T-Lymphocyte - genetics ; Antigens, Differentiation, T-Lymphocyte - immunology ; Cell Proliferation - drug effects ; Cell Survival - immunology ; Coculture Techniques ; Cytokine Receptor gp130 - genetics ; Cytokine Receptor gp130 - immunology ; Cytotoxicity ; Cytotoxicity, Immunologic ; Dendritic Cells - cytology ; Dendritic Cells - drug effects ; Dendritic Cells - immunology ; Gene Expression Regulation ; HCT116 Cells ; Humans ; IFN‐γ ; IL‐18 ; IL‐27 ; Immune system ; Interleukin-18 - immunology ; Interleukin-18 - pharmacology ; Interleukin-2 Receptor alpha Subunit - genetics ; Interleukin-2 Receptor alpha Subunit - immunology ; Interleukins - immunology ; Interleukins - pharmacology ; Killer Cells, Natural - cytology ; Killer Cells, Natural - drug effects ; Killer Cells, Natural - immunology ; Lectins, C-Type - genetics ; Lectins, C-Type - immunology ; NK cells ; Primary Cell Culture ; Recombinant Proteins - pharmacology ; Signal Transduction</subject><ispartof>European journal of immunology, 2015-01, Vol.45 (1), p.192-202</ispartof><rights>2014 WILEY‐VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><rights>2014 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim.</rights><rights>2015 WILEY-VCH Verlag GmbH &amp; Co. KGaA, Weinheim</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5067-b16338bb7bca7f9676a93f874190d3b6b809eaab2b7f0800c6751cfc61a3c6733</citedby><cites>FETCH-LOGICAL-c5067-b16338bb7bca7f9676a93f874190d3b6b809eaab2b7f0800c6751cfc61a3c6733</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Feji.201444699$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Feji.201444699$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,1434,27929,27930,45579,45580,46414,46838</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25308526$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ziblat, Andrea</creatorcontrib><creatorcontrib>Domaica, Carolina I.</creatorcontrib><creatorcontrib>Spallanzani, Raúl G.</creatorcontrib><creatorcontrib>Iraolagoitia, Ximena L. Raffo</creatorcontrib><creatorcontrib>Rossi, Lucas E.</creatorcontrib><creatorcontrib>Avila, Damián E.</creatorcontrib><creatorcontrib>Torres, Nicolás I.</creatorcontrib><creatorcontrib>Fuertes, Mercedes B.</creatorcontrib><creatorcontrib>Zwirner, Norberto W.</creatorcontrib><title>IL‐27 stimulates human NK‐cell effector functions and primes NK cells for IL‐18 responsiveness</title><title>European journal of immunology</title><addtitle>Eur J Immunol</addtitle><description>IL‐27, a member of the IL‐12 family of cytokines, is produced by APCs, and displays pro‐ and anti‐inflammatory effects. How IL‐27 affects human NK cells still remains unknown. In this study, we observed that mature DCs secreted IL‐27 and that blockade of IL‐27R (CD130) reduced the amount of IFN‐γ produced by NK cells during their coculture, showing the importance of IL‐27 during DC–NK‐cell crosstalk. Accordingly, human rIL‐27 stimulated IFN‐γ secretion by NK cells in a STAT1‐dependent manner, induced upregulation of CD25 and CD69 on NK cells, and displayed a synergistic effect with IL‐18. Preincubation experiments demonstrated that IL‐27 primed NK cells for IL‐18‐induced IFN‐γ secretion, which was associated with an IL‐27‐driven upregulation of T‐bet expression. Also, IL‐27 triggered NKp46‐dependent NK‐cell‐mediated cytotoxicity against Raji, T‐47D, and HCT116 cells, and IL‐18 enhanced this cytotoxic response. Such NK‐cell‐mediated cytotoxicity involved upregulation of perforin, granule exocytosis, and TRAIL‐mediated cytotoxicity but not Fas‐FasL interaction. Moreover, IL‐27 also potentiated Ab‐dependent cell‐mediated cytotoxicity against mAb‐coated target cells. Taken together, IL‐27 stimulates NK‐cell effector functions, which might be relevant in different physiological and pathological situations.</description><subject>Antibodies, Monoclonal - pharmacology</subject><subject>Antigens</subject><subject>Antigens, CD - genetics</subject><subject>Antigens, CD - immunology</subject><subject>Antigens, Differentiation, T-Lymphocyte - genetics</subject><subject>Antigens, Differentiation, T-Lymphocyte - immunology</subject><subject>Cell Proliferation - drug effects</subject><subject>Cell Survival - immunology</subject><subject>Coculture Techniques</subject><subject>Cytokine Receptor gp130 - genetics</subject><subject>Cytokine Receptor gp130 - immunology</subject><subject>Cytotoxicity</subject><subject>Cytotoxicity, Immunologic</subject><subject>Dendritic Cells - cytology</subject><subject>Dendritic Cells - drug effects</subject><subject>Dendritic Cells - immunology</subject><subject>Gene Expression Regulation</subject><subject>HCT116 Cells</subject><subject>Humans</subject><subject>IFN‐γ</subject><subject>IL‐18</subject><subject>IL‐27</subject><subject>Immune system</subject><subject>Interleukin-18 - immunology</subject><subject>Interleukin-18 - pharmacology</subject><subject>Interleukin-2 Receptor alpha Subunit - genetics</subject><subject>Interleukin-2 Receptor alpha Subunit - immunology</subject><subject>Interleukins - immunology</subject><subject>Interleukins - pharmacology</subject><subject>Killer Cells, Natural - cytology</subject><subject>Killer Cells, Natural - drug effects</subject><subject>Killer Cells, Natural - immunology</subject><subject>Lectins, C-Type - genetics</subject><subject>Lectins, C-Type - immunology</subject><subject>NK cells</subject><subject>Primary Cell Culture</subject><subject>Recombinant Proteins - pharmacology</subject><subject>Signal Transduction</subject><issn>0014-2980</issn><issn>1521-4141</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0btOIzEUBmAL7YpkgZIWWdqGZsLxfVwiBGwgggbqke3YYqK5hPEMKB2PsM-4T4KHsCm2QFvZsj_98vGP0DGBGQGgZ35VzigQzrnUeg9NiaAk44STb2gK6TyjOocJ-hHjCgC0FHofTahgkAsqp2g5X_x5-00Vjn1ZD5XpfcRPQ20afHebLpyvKuxD8K5vOxyGxvVl20RsmiVed2Wd9N0tHlXEIYmPNJLjzsd1cuWLb3yMh-h7MFX0R5_rAXq8uny4-JUt7q_nF-eLzAmQKrNEMpZbq6wzKmippNEs5IoTDUtmpc1Be2MstSpADuCkEsQFJ4lhac_YATrd5q679nnwsS_qMo6PM41vh1gQKbiUGpj-H0qZUpCPqT__oat26Jo0SFKcC6W1lEllW-W6NsbOh2L8H9NtCgLF2FSRmip2TSV_8pk62Novd_pvNQnQLXgtK7_5Oq24vJkzIhR7B8mZnnU</recordid><startdate>201501</startdate><enddate>201501</enddate><creator>Ziblat, Andrea</creator><creator>Domaica, Carolina I.</creator><creator>Spallanzani, Raúl G.</creator><creator>Iraolagoitia, Ximena L. Raffo</creator><creator>Rossi, Lucas E.</creator><creator>Avila, Damián E.</creator><creator>Torres, Nicolás I.</creator><creator>Fuertes, Mercedes B.</creator><creator>Zwirner, Norberto W.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>201501</creationdate><title>IL‐27 stimulates human NK‐cell effector functions and primes NK cells for IL‐18 responsiveness</title><author>Ziblat, Andrea ; Domaica, Carolina I. ; Spallanzani, Raúl G. ; Iraolagoitia, Ximena L. Raffo ; Rossi, Lucas E. ; Avila, Damián E. ; Torres, Nicolás I. ; Fuertes, Mercedes B. ; Zwirner, Norberto W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5067-b16338bb7bca7f9676a93f874190d3b6b809eaab2b7f0800c6751cfc61a3c6733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Antibodies, Monoclonal - pharmacology</topic><topic>Antigens</topic><topic>Antigens, CD - genetics</topic><topic>Antigens, CD - immunology</topic><topic>Antigens, Differentiation, T-Lymphocyte - genetics</topic><topic>Antigens, Differentiation, T-Lymphocyte - immunology</topic><topic>Cell Proliferation - drug effects</topic><topic>Cell Survival - immunology</topic><topic>Coculture Techniques</topic><topic>Cytokine Receptor gp130 - genetics</topic><topic>Cytokine Receptor gp130 - immunology</topic><topic>Cytotoxicity</topic><topic>Cytotoxicity, Immunologic</topic><topic>Dendritic Cells - cytology</topic><topic>Dendritic Cells - drug effects</topic><topic>Dendritic Cells - immunology</topic><topic>Gene Expression Regulation</topic><topic>HCT116 Cells</topic><topic>Humans</topic><topic>IFN‐γ</topic><topic>IL‐18</topic><topic>IL‐27</topic><topic>Immune system</topic><topic>Interleukin-18 - immunology</topic><topic>Interleukin-18 - pharmacology</topic><topic>Interleukin-2 Receptor alpha Subunit - genetics</topic><topic>Interleukin-2 Receptor alpha Subunit - immunology</topic><topic>Interleukins - immunology</topic><topic>Interleukins - pharmacology</topic><topic>Killer Cells, Natural - cytology</topic><topic>Killer Cells, Natural - drug effects</topic><topic>Killer Cells, Natural - immunology</topic><topic>Lectins, C-Type - genetics</topic><topic>Lectins, C-Type - immunology</topic><topic>NK cells</topic><topic>Primary Cell Culture</topic><topic>Recombinant Proteins - pharmacology</topic><topic>Signal Transduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ziblat, Andrea</creatorcontrib><creatorcontrib>Domaica, Carolina I.</creatorcontrib><creatorcontrib>Spallanzani, Raúl G.</creatorcontrib><creatorcontrib>Iraolagoitia, Ximena L. Raffo</creatorcontrib><creatorcontrib>Rossi, Lucas E.</creatorcontrib><creatorcontrib>Avila, Damián E.</creatorcontrib><creatorcontrib>Torres, Nicolás I.</creatorcontrib><creatorcontrib>Fuertes, Mercedes B.</creatorcontrib><creatorcontrib>Zwirner, Norberto W.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ziblat, Andrea</au><au>Domaica, Carolina I.</au><au>Spallanzani, Raúl G.</au><au>Iraolagoitia, Ximena L. Raffo</au><au>Rossi, Lucas E.</au><au>Avila, Damián E.</au><au>Torres, Nicolás I.</au><au>Fuertes, Mercedes B.</au><au>Zwirner, Norberto W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>IL‐27 stimulates human NK‐cell effector functions and primes NK cells for IL‐18 responsiveness</atitle><jtitle>European journal of immunology</jtitle><addtitle>Eur J Immunol</addtitle><date>2015-01</date><risdate>2015</risdate><volume>45</volume><issue>1</issue><spage>192</spage><epage>202</epage><pages>192-202</pages><issn>0014-2980</issn><eissn>1521-4141</eissn><coden>EJIMAF</coden><abstract>IL‐27, a member of the IL‐12 family of cytokines, is produced by APCs, and displays pro‐ and anti‐inflammatory effects. How IL‐27 affects human NK cells still remains unknown. In this study, we observed that mature DCs secreted IL‐27 and that blockade of IL‐27R (CD130) reduced the amount of IFN‐γ produced by NK cells during their coculture, showing the importance of IL‐27 during DC–NK‐cell crosstalk. Accordingly, human rIL‐27 stimulated IFN‐γ secretion by NK cells in a STAT1‐dependent manner, induced upregulation of CD25 and CD69 on NK cells, and displayed a synergistic effect with IL‐18. Preincubation experiments demonstrated that IL‐27 primed NK cells for IL‐18‐induced IFN‐γ secretion, which was associated with an IL‐27‐driven upregulation of T‐bet expression. Also, IL‐27 triggered NKp46‐dependent NK‐cell‐mediated cytotoxicity against Raji, T‐47D, and HCT116 cells, and IL‐18 enhanced this cytotoxic response. Such NK‐cell‐mediated cytotoxicity involved upregulation of perforin, granule exocytosis, and TRAIL‐mediated cytotoxicity but not Fas‐FasL interaction. Moreover, IL‐27 also potentiated Ab‐dependent cell‐mediated cytotoxicity against mAb‐coated target cells. Taken together, IL‐27 stimulates NK‐cell effector functions, which might be relevant in different physiological and pathological situations.</abstract><cop>Germany</cop><pub>Wiley Subscription Services, Inc</pub><pmid>25308526</pmid><doi>10.1002/eji.201444699</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0014-2980
ispartof European journal of immunology, 2015-01, Vol.45 (1), p.192-202
issn 0014-2980
1521-4141
language eng
recordid cdi_proquest_miscellaneous_1654669039
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via Wiley Online Library; Wiley Online Library (Open Access Collection)
subjects Antibodies, Monoclonal - pharmacology
Antigens
Antigens, CD - genetics
Antigens, CD - immunology
Antigens, Differentiation, T-Lymphocyte - genetics
Antigens, Differentiation, T-Lymphocyte - immunology
Cell Proliferation - drug effects
Cell Survival - immunology
Coculture Techniques
Cytokine Receptor gp130 - genetics
Cytokine Receptor gp130 - immunology
Cytotoxicity
Cytotoxicity, Immunologic
Dendritic Cells - cytology
Dendritic Cells - drug effects
Dendritic Cells - immunology
Gene Expression Regulation
HCT116 Cells
Humans
IFN‐γ
IL‐18
IL‐27
Immune system
Interleukin-18 - immunology
Interleukin-18 - pharmacology
Interleukin-2 Receptor alpha Subunit - genetics
Interleukin-2 Receptor alpha Subunit - immunology
Interleukins - immunology
Interleukins - pharmacology
Killer Cells, Natural - cytology
Killer Cells, Natural - drug effects
Killer Cells, Natural - immunology
Lectins, C-Type - genetics
Lectins, C-Type - immunology
NK cells
Primary Cell Culture
Recombinant Proteins - pharmacology
Signal Transduction
title IL‐27 stimulates human NK‐cell effector functions and primes NK cells for IL‐18 responsiveness
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T00%3A56%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=IL%E2%80%9027%20stimulates%20human%20NK%E2%80%90cell%20effector%20functions%20and%20primes%20NK%20cells%20for%20IL%E2%80%9018%20responsiveness&rft.jtitle=European%20journal%20of%20immunology&rft.au=Ziblat,%20Andrea&rft.date=2015-01&rft.volume=45&rft.issue=1&rft.spage=192&rft.epage=202&rft.pages=192-202&rft.issn=0014-2980&rft.eissn=1521-4141&rft.coden=EJIMAF&rft_id=info:doi/10.1002/eji.201444699&rft_dat=%3Cproquest_cross%3E1654669039%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1644579966&rft_id=info:pmid/25308526&rfr_iscdi=true